Mersana Therapeutics Inc (MRSN) is higher by Friday morning, with the stock gaining 1.82% in pre-market trading to 1.68. MRSN's short-term technical score of 50 indicates that the stock has traded as bullishly as over the last month than 50% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, MRSN ranks higher than 68% of stocks. Mersana Therapeutics Inc has risen 38.66% over the past month, closing at $1.42 on November 3. During this period of time, the stock fell as low as $1.20 and as high as $1.73. MRSN has an average analyst recommendation of Buy. The company has an average price target of $5.33.
MRSN has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on MRSN!